about
Effect of Anticoagulants on Amyloid β-Protein Precursor and Amyloid Beta Levels in Plasma.Natural and Synthetic Neurotoxins in Our Environment: From Alzheimer’s Disease (AD) to Autism Spectrum Disorder (ASD)Examining the relationship between head trauma and neurodegenerative disease: A review of epidemiology, pathology and neuroimaging techniquesSelective Neuronal and Brain Regional Expession of IL-2 in IL2P 8-GFP Transgenic Mice: Relation to Sensorimotor Gating.CSF and Brain Indices of Insulin Resistance, Oxidative Stress and Neuro-Inflammation in Early versus Late Alzheimer's DiseaseImaging Brain Metabolism and Pathology in Alzheimer's Disease with Positron Emission Tomography.Differences in Cerebrospinal Fluid Biomarkers between Clinically Diagnosed Idiopathic Normal Pressure Hydrocephalus and Alzheimer's Disease.Microbial Sources of Amyloid and Relevance to Amyloidogenesis and Alzheimer's Disease (AD).Role of Personalized Medicine in the Identification and Characterization of Parkinson's Disease in Asymptomatic Subjects.The Role of Upregulated APOE in Alzheimer's Disease Etiology.Targeting Alzheimer's Disease Neuro-Metabolic Dysfunction with a Small Molecule Nuclear Receptor Agonist (T3D-959) Reverses Disease Pathologies.Blood Derived Induced Pluripotent Stem Cells (iPSCs): Benefits, Challenges and the Road Ahead.Rust on the Brain from Microbleeds and Its Relevance to Alzheimer Studies: Invited Commentary on Cacciottolo Neurobiology of Aging, 2016.Neurotoxin-Induced Catecholaminergic Loss in the Colonic Myenteric Plexus of Rhesus MonkeysPoor Sleep as a Precursor to Cognitive Decline in Down Syndrome : A Hypothesis.Time-Dependent Compensatory Responses to Chronic Neuroinflammation in Hippocampus and Brainstem: The Potential Role of Glutamate NeurotransmissionGeneration of Reactive Oxygen Species (ROS) and Pro-Inflammatory Signaling in Human Brain Cells in Primary Culture.A Comparative White Matter Study with Parkinson's disease, Parkinson's Disease with Dementia and Alzheimer's Disease.Magnetic Resonance Imaging (MRI) in Parkinson's Disease.The Role of TREM2 in Alzheimer's Disease and Other Neurological Disorders.Effect of Moderate to Vigorous Physical Activity Intervention on Improving Dementia Family Caregiver Physical Function: A Randomized Controlled Trial.Recent Perspectives on APP, Secretases, Endosomal Pathways and How they Influence Alzheimer's Related Pathological Changes in Down SyndromeRapid Eye Movement Sleep Homeostatic Response: A Potential Marker for Early Detection of Parkinson's Disease.Sensory, Motor and Intrinsic Mechanisms of Thalamic Activity related to Organic and Psychogenic Dystonia.Chaperone-dependent Neurodegeneration: A Molecular Perspective on Therapeutic Intervention.Loss of Neuronal Phenotype and Neurodegeneration: Effects of T Lymphocytes and Brain Interleukin-2.Alterations in micro RNA-messenger RNA (miRNA-mRNA) Coupled Signaling Networks in Sporadic Alzheimer's Disease (AD) Hippocampal CA1Exome Sequencing of Extended Families with Alzheimer's Disease Identifies Novel Genes Implicated in Cell Immunity and Neuronal Function.Systemic Inflammation in C57BL/6J Mice Receiving Dietary Aluminum Sulfate; Up-Regulation of the Pro-Inflammatory Cytokines IL-6 and TNFα, C-Reactive Protein (CRP) and miRNA-146a in Blood Serum.Calcium Dysregulation in Alzheimer's Disease: A Target for New Drug Development.Static and Dynamic Cognitive Reserve Proxy Measures: Interactions with Alzheimer's Disease Neuropathology and Cognition.Subcortical Effects on Voice and Fluency in Dysarthria: Observations from Subthalamic Nucleus Stimulation.Occipital and Cingulate Hypometabolism are Significantly Under-Reported on 18-Fluorodeoxyglucose Positron Emission Tomography Scans of Patients with Lewy Body Dementia.Towards a circuit-level understanding of hippocampal CA1 dysfunction in Alzheimer’s disease across anatomical axes.microRNAs in Neurodegeneration: Current Findings and Potential Impacts.A Pleotrophic Age for Alzheimer and Parkinson diseaseWhat is the Relationship between Higher Levels of Education Delaying Age at Onset of Dementia?Exercise to Prevent Cognitive Decline and Alzheimer’s disease: For Whom, When, What, and (most importantly) How Much?A Biomedical Imaging Analysis of the Prevalent Neuropsychiatric DisordersMeasuring Quality of Life in Intellectually Disabled Persons with Dementia with the Italian Version of the Quality of Life in Late-Stage Dementia (QUALID) Scale
P1433
Q24303677-F91DE798-0588-4DCD-B55B-EA4F6C6137DDQ27468568-D5A370F3-7D48-4C2D-B8B3-5A6A8A804C9EQ28395854-CA557817-9216-4063-9AB6-62E55C3BEE4BQ30442787-F5C0FCB0-3BDF-48BB-900A-A0987E4B6423Q33896118-62CD7D4A-DF88-4C5C-96D5-A167C93652AFQ34378321-D9778664-276E-4FFD-AB1A-1CBD7B52F76EQ35557939-D11C9558-92E9-426D-951C-A78E6C064A2BQ35597184-00D01B50-60A3-4D0D-993D-4CA8473ED642Q36282598-8C20409E-596F-40FE-B47A-FA1892C771DFQ36813059-22EFD3FB-A175-4C1F-A8A5-DDEAFC79C9D8Q37164474-071A8E02-BE8B-42AA-A1E1-BC55362E40DBQ37427137-7BAFCBCE-AA27-4831-B04E-28FA77B54815Q37544679-E7A95ADD-62B2-4D18-90A4-9D6B23943898Q37579221-338E2DAF-1636-4EBE-B281-624E135D74BEQ37591286-B2969940-09EA-4F19-962B-7A7D7E919151Q37612310-C28EFF9F-AAD4-4B3A-B3AE-F190652E6B3BQ37627211-48A6FF28-386B-44B9-893D-C615C75CAB93Q37691518-1F5642D4-2890-4CB8-A900-9210ECEEA02EQ38281082-E81B9E87-0025-4A76-BE7F-5E25E632B9DCQ38348923-86088B4F-47AC-4543-87E1-30752FA60A9CQ38650617-46AF690E-13D8-4B04-986F-3AAECADD535AQ38982671-C95E33F6-2241-4715-8A9E-A5E2E02CBD7EQ41312041-15994AE4-552D-4FE2-8838-92A35787ECCFQ41700192-AA177972-E142-4E6C-A434-5D54B8FBF657Q41786144-9A2134B3-4936-4749-ACD2-4EBD98551B49Q41969027-466853B7-A1E0-44CF-98D1-654F8C21C99BQ42379533-0291A7F2-1DB3-4A7B-A077-6317BC402C7AQ47169529-D0577CF7-10D4-45B9-A893-AD2742BCEC36Q47707658-F7DF5DAD-218C-4930-A4A5-C193ACCB85F8Q47928995-3921BF19-DC57-419E-B825-15EA4A96CDF4Q49165313-5925A4C3-5A57-458B-9CBE-1A089EAACDB3Q49873789-F0C45111-15B2-49F2-A7A4-90E619A5CDE6Q55124569-6611D068-3173-4126-B6A0-60E857CA5CAFQ55176465-DF9CD53C-222C-4871-BE19-58D9B183F689Q55231712-6A768C0B-1322-4D83-BCDB-7044A72DF383Q57341223-C2B16900-9F2F-4252-8444-BD4BAFE99CCDQ58485909-F2461913-29DF-4B05-A9DE-A7CC731D582BQ58485913-62B7EBAA-C81B-471F-AE5B-DFE6A969547AQ58887500-A490B866-1EA7-49A5-8364-E9199E0E8D7CQ59293296-FCC38856-F821-4C83-8B1F-BB5D006F56C1
P1433
description
czasopismo naukowe
@pl
journal
@en
revista científica
@es
videnskabeligt tidsskrift
@da
wetenschappelijk tijdschrift
@nl
wissenschaftliche Fachzeitschrift
@de
name
Journal of Alzheimer's disease & Parkinsonism
@ast
Journal of Alzheimer's disease & Parkinsonism
@da
Journal of Alzheimer's disease & Parkinsonism
@de
Journal of Alzheimer's disease & Parkinsonism
@en
Journal of Alzheimer's disease & Parkinsonism
@es
Journal of Alzheimer's disease & Parkinsonism
@fo
Journal of Alzheimer's disease & Parkinsonism
@fr
Journal of Alzheimer's disease & Parkinsonism
@is
Journal of Alzheimer's disease & Parkinsonism
@kl
Journal of Alzheimer's disease & Parkinsonism
@nb
type
label
Journal of Alzheimer's disease & Parkinsonism
@ast
Journal of Alzheimer's disease & Parkinsonism
@da
Journal of Alzheimer's disease & Parkinsonism
@de
Journal of Alzheimer's disease & Parkinsonism
@en
Journal of Alzheimer's disease & Parkinsonism
@es
Journal of Alzheimer's disease & Parkinsonism
@fo
Journal of Alzheimer's disease & Parkinsonism
@fr
Journal of Alzheimer's disease & Parkinsonism
@is
Journal of Alzheimer's disease & Parkinsonism
@kl
Journal of Alzheimer's disease & Parkinsonism
@nb
altLabel
J Alzheimers Dis Parkinsonism
@en
prefLabel
Journal of Alzheimer's disease & Parkinsonism
@ast
Journal of Alzheimer's disease & Parkinsonism
@da
Journal of Alzheimer's disease & Parkinsonism
@de
Journal of Alzheimer's disease & Parkinsonism
@en
Journal of Alzheimer's disease & Parkinsonism
@es
Journal of Alzheimer's disease & Parkinsonism
@fo
Journal of Alzheimer's disease & Parkinsonism
@fr
Journal of Alzheimer's disease & Parkinsonism
@is
Journal of Alzheimer's disease & Parkinsonism
@kl
Journal of Alzheimer's disease & Parkinsonism
@nb
P3181
P1055
P1277
P1476
Journal of Alzheimer's disease & Parkinsonism
@en